Atencion primaria · 1994
[The seroepidemiology of the hepatitis A virus in children and adolescents].
Сравнительное исследованиеАннотация на английскомСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lasheras Lozano M L, Gil Miguel A, Santos Santos M, Rey Calero J
Аннотация
OBJECTIVE: To know the prevalence of antibodies against hepatitis A virus (anti-HAV) in a population of children and teenagers pertaining to three municipalities of the Autonomous Community of Madrid (CAM).
DESIGN: Cross-study. SITE. The study was conducted in three public schools centers of the municipalities located in the Southeast of the (CAM).
PATIENTS AND OTHER PARTICIPANTS: Students between the ages of 6 and 17 whose parents authorized them to be tested.
MEASUREMENTS AND MAIN RESULTS: The presence of anti-HAV antibodies in the serum of 729 students was investigated. Thirty eight of them presented a positive mark, which indicates a prevalence of 5.34%. In the males, the prevalence was 5.7% and in the females it was 5%.
CONCLUSIONS: The prevalence of anti-HAV antibodies is low in our population, agreeing with the delay in the age that the infection is acquired according to various publications.
DESIGN: Cross-study. SITE. The study was conducted in three public schools centers of the municipalities located in the Southeast of the (CAM).
PATIENTS AND OTHER PARTICIPANTS: Students between the ages of 6 and 17 whose parents authorized them to be tested.
MEASUREMENTS AND MAIN RESULTS: The presence of anti-HAV antibodies in the serum of 729 students was investigated. Thirty eight of them presented a positive mark, which indicates a prevalence of 5.34%. In the males, the prevalence was 5.7% and in the females it was 5%.
CONCLUSIONS: The prevalence of anti-HAV antibodies is low in our population, agreeing with the delay in the age that the infection is acquired according to various publications.